Drug-coated balloons (DCBs) are a novel treatment strategy for coronary artery disease based on the fast and homogenous transfer of antiproliferative drugs into the vessel wall during single …

2020年5月27日 · Patient-level data from 10 randomized trials comparing DCB angioplasty to repeat drug-eluting stent (DES) implantation in the treatment of coronary ISR (710 patients …

2025年2月1日 · Importance: Drug-coated balloon (DCB) angioplasty has emerged as an alternative to drug-eluting stent (DES) implantation for percutaneous coronary intervention …

Drug-coated balloon (DCB) technology was developed to deliver the antiproliferative drugs to the vessel wall without leaving any permanent prosthesis or durable polymers. The absence of …

2024年9月14日 · Drug-coated balloon (DCB) angioplasty is a novel approach for the treatment of coronary artery disease. 4 Following adequate lesion preparation, the expansion of a DCB can …

3 天之前 · Purpose of Review The purpose of this work is to review the role of drug-coated balloons (DCBs) in contemporary coronary artery disease (CAD) management by focusing on …

2020年6月22日 · Drug-coated balloons (DCBs) are a novel treatment strategy for coronary artery disease based on the fast and homogenous transfer of antiproliferative drugs into the vessel …

Non-stent-based local drug delivery by a drug-coated balloon (DCB) has been investigated, as it leaves no metallic mesh. A DCB consists of a semicompliant balloon coated with …

Drug coated balloons (DCBs) are currently indicated in guidelines as a first choice option in the management of instant restenosis, whereas their use in de novo lesions is still debated.

every PCI should aim at using the DCB-only strategy, which implies a similar approach for every lesion preparation. This requires an optimal angioplasty result, which may be assessed using …

5 天之前 · A total of 230 patients were randomised to the sirolimus DCB or the paclitaxel DCB group in a 1:1 ratio. Angiographic and clinical follow-ups were planned at 9 months and 1 year, …

2016年7月26日 · Historically, in-stent restenosis represents the first clinical application of DCB in coronary arteries and is where its most robust scientific evidence is found. In 2006, the first …

In this multicenter, randomized controlled trial, patients with true coronary bifurcations who had side branch diameter stenosis of ≥70% after main vessel stenting at 22 centers in China, …

2025年3月13日 · The UH Harrington Heart & Vascular Institute is launching a robust scientific program of five upcoming industry-sponsored DCB trials, with plans to submit them for IRB …

Therefore, we aimed to evaluate angiographic and clinical outcomes of the two most effective treatments DES vs. drug-eluting balloon (DCB) for patients with DES-ISR. Methods: This meta …

4 天之前 · This study analyzed 317 patients who underwent DCB-based intervention for de novo CAD and angiographic follow-up: SR (successful, stent-like result: diameter stenosis < 20% at …

2 天之前 · Background Drug-coated balloon (DCB) are effective treatment options for patients with coronary artery disease and using of scoring or cutting balloon before the DCB usage were …

2025年3月15日 · Consecutive patients with de novo coronary artery disease who underwent PCI with intention-to-treat DCB angioplasty, with or without stent implantation, were retrospectively …

Drug-coated balloon (DCB) angioplasty has emerged as a promising option. Devoid of a metallic scaffold, it may mitigate many of the risks of stent-related complications. Herein we present …

2021年7月21日 · Currently the two methods to ensure successful DCB treatment of a stenotic lesion are angiography or physiology-guided DCB application. This review will evaluate these …